Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(267)
•••
Comment by LaserStock29on Apr 01, 2020 11:45am
183 Views
Post# 30868409

RE:RE:RE:RE:Good bet TLT is confidentially sharing Ph2 data with FDA

RE:RE:RE:RE:Good bet TLT is confidentially sharing Ph2 data with FDA
Yajne wrote: seems to me that a NR of that magnitude would be 'halt' worthy...

Hempdoc wrote: I'll take a IND/BTD Combo to go please...that would break us through a buck...




Funny thing.. my bank account isn't confidentially growing


Lots of biotechs on 'stunningly good nr's   gap up.... yes that's right.. and large.. 

I see no reason why if we have 6/6 with p1 p2 at 2nd treatment why we dont 'open' at .60 cents and start running. 

That's about where TLT crashed the pps from the last agm anyways.. so it's been a fugaze ride ever since then of being undervalued.


In one NR.. boom erased and we can get that Phase 1 valuation of 160m in one shot. 


No i know what most here want... lets release a bombshell and open at .19 and sell at .what .38.. say.. i cant believe no one got in.... suckers.

call it a 'double top' or some shi*



Bullboard Posts
Dealroom for high-potential pre-IPO opportunities